Disruption of the CX3CL1–CX3CR1 axis leads to dysregulation of microglial and neuronal damage in various animal models of neurodegenerative diseases such as Parkinson’s disease, ischemic stroke, Alzheimer’s disease, and mild traumatic brain injury [63,64,65,66]. This evidence concerns the gene CX3CL1 and Parkinson disease.